TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge March 10, 1978
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials May 10, 2002
